Cargando…

Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions

Inflammatory bowel disease (IBD) is a chronic relapsing-remitting inflammatory disease of the gastrointestinal tract. Patients are usually diagnosed in adolescence and early adulthood and need lifelong treatment. In recent years, it has been found that diet plays an important role in the pathogenesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ban, Quan-Yao, Liu, Mei, Ding, Ning, Chen, Ying, Lin, Qiong, Zha, Juan-Min, He, Wei-Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207447/
https://www.ncbi.nlm.nih.gov/pubmed/35734374
http://dx.doi.org/10.3389/fnut.2022.794169
_version_ 1784729533709025280
author Ban, Quan-Yao
Liu, Mei
Ding, Ning
Chen, Ying
Lin, Qiong
Zha, Juan-Min
He, Wei-Qi
author_facet Ban, Quan-Yao
Liu, Mei
Ding, Ning
Chen, Ying
Lin, Qiong
Zha, Juan-Min
He, Wei-Qi
author_sort Ban, Quan-Yao
collection PubMed
description Inflammatory bowel disease (IBD) is a chronic relapsing-remitting inflammatory disease of the gastrointestinal tract. Patients are usually diagnosed in adolescence and early adulthood and need lifelong treatment. In recent years, it has been found that diet plays an important role in the pathogenesis of IBD. Diet can change intestinal barrier function, affect the structure and function of intestinal flora, and promote immune disorder, thus promoting inflammation. Many patients believe that diet plays a role in the onset and treatment of the disease and changes their diet spontaneously. This review provides some insights into how nutraceuticals regulate intestinal immune homeostasis and improve intestinal barrier function. We reviewed the research results of dietary fiber, polyphenols, bioactive peptides, and other nutraceuticals in the prevention and treatment of IBD and sought better alternative or supplementary treatment methods for IBD patients.
format Online
Article
Text
id pubmed-9207447
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92074472022-06-21 Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions Ban, Quan-Yao Liu, Mei Ding, Ning Chen, Ying Lin, Qiong Zha, Juan-Min He, Wei-Qi Front Nutr Nutrition Inflammatory bowel disease (IBD) is a chronic relapsing-remitting inflammatory disease of the gastrointestinal tract. Patients are usually diagnosed in adolescence and early adulthood and need lifelong treatment. In recent years, it has been found that diet plays an important role in the pathogenesis of IBD. Diet can change intestinal barrier function, affect the structure and function of intestinal flora, and promote immune disorder, thus promoting inflammation. Many patients believe that diet plays a role in the onset and treatment of the disease and changes their diet spontaneously. This review provides some insights into how nutraceuticals regulate intestinal immune homeostasis and improve intestinal barrier function. We reviewed the research results of dietary fiber, polyphenols, bioactive peptides, and other nutraceuticals in the prevention and treatment of IBD and sought better alternative or supplementary treatment methods for IBD patients. Frontiers Media S.A. 2022-06-06 /pmc/articles/PMC9207447/ /pubmed/35734374 http://dx.doi.org/10.3389/fnut.2022.794169 Text en Copyright © 2022 Ban, Liu, Ding, Chen, Lin, Zha and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Ban, Quan-Yao
Liu, Mei
Ding, Ning
Chen, Ying
Lin, Qiong
Zha, Juan-Min
He, Wei-Qi
Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
title Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
title_full Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
title_fullStr Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
title_full_unstemmed Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
title_short Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
title_sort nutraceuticals for the treatment of ibd: current progress and future directions
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207447/
https://www.ncbi.nlm.nih.gov/pubmed/35734374
http://dx.doi.org/10.3389/fnut.2022.794169
work_keys_str_mv AT banquanyao nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections
AT liumei nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections
AT dingning nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections
AT chenying nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections
AT linqiong nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections
AT zhajuanmin nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections
AT heweiqi nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections